Boehringer Ingelheim opens U.S. animal health HQ in Georgia
Bottom line
Boehringer Ingelheim has opened its new U.S. Animal Health headquarters at Medley in Johns Creek, Georgia, completing a move from Duluth and bringing roughly 500 employees into a 73,000-square-foot office within the mixed-use development. The opening keeps the company’s U.S. animal health leadership footprint in Georgia while linking the new headquarters more closely with its existing research and manufacturing operations in Athens and Gainesville. Boehringer’s U.S. locations page still recently listed Duluth as the headquarters, underscoring that this is a fresh operational change now being formalized. (rebusinessonline.com)
Why it matters: For veterinary professionals, the move is less about a new address and more about how one of the industry’s largest animal health companies is organizing for growth. Boehringer has continued investing in Georgia, including a $57 million expansion of its Animal Health Global Innovation center in Athens, and company and state officials have framed the Johns Creek site as part of a broader life sciences network spanning companion animal, livestock, vaccine, and R&D work. That kind of clustering can matter for product development, field support, recruiting, and future partnerships that touch both practice and production animal medicine. (gov.georgia.gov)
What to watch: Watch for updated corporate materials, hiring activity, and any signals that the new headquarters translates into expanded commercial, R&D, or veterinary engagement initiatives in the Southeast. (animalhealth.boehringer-ingelheim.com)
Boehringer Ingelheim has officially opened its new U.S. Animal Health headquarters in Johns Creek, Georgia, marking the latest step in a broader buildout of its animal health footprint in the state. The company is relocating about 500 employees from Duluth into a 73,000-square-foot office at Medley, a 43-acre mixed-use development that local officials have positioned as a centerpiece of Johns Creek’s town center strategy. (rebusinessonline.com)
The move didn’t come out of nowhere. In April 2025, commercial real estate and local development reports said Boehringer had leased space at Medley and planned to make it the new U.S. Animal Health headquarters in summer 2026. That followed years of investment in Georgia by the company, including a 2022 announcement of a $57 million expansion in Athens to add laboratory space and research capacity. At that time, Georgia officials said Boehringer had invested more than $100 million in its Georgia facilities since 2018. (rebusinessonline.com)
What changed now is that the headquarters is no longer a future plan but an operating site. Boehringer’s own U.S. locations page still recently identified Duluth as its headquarters, which suggests the public-facing transition is still catching up to the physical move. At the opening ceremony, company leaders emphasized the Johns Creek site’s role in connecting the headquarters to a broader Georgia-based ecosystem that includes research and manufacturing in Athens and poultry vaccine manufacturing in Gainesville. Gov. Brian Kemp said the company now employs more than 1,500 people across Georgia, while Boehringer’s own older materials had put the Georgia workforce above 1,200. That gap likely reflects more recent growth, though the figures come from different points in time. (animalhealth.boehringer-ingelheim.com)
There are also practical details behind the headline. The headquarters occupies two floors of a reworked office building at Medley, and the lease was described as the largest new Class A office lease north of Atlanta’s Perimeter in roughly five years. Local coverage of the opening portrayed the office as fully active even as the wider Medley development remains under construction, making Boehringer one of the anchor tenants helping bring the project to life. (rebusinessonline.com)
Public comments at the opening offered some insight into how Boehringer wants the move to be read. Peter Ploeger, the company’s U.S. Animal Health country managing director, said Johns Creek stood out quickly and described the office as designed around collaboration rather than rows of fixed workstations. Dr. Armin Wiesler, the board member responsible for Boehringer’s global Animal Health business, called the opening “the beginning of a new chapter,” and tied the company’s work to the connection between animal and human health. Those remarks are ceremonial, but they align with a familiar industry message: headquarters design and location are being used to support recruitment, cross-functional work, and closer ties between commercial teams and innovation programs. (northatlantastar.com)
Why it matters: For veterinary professionals, especially those working with companion animals, food animals, or both, headquarters moves can seem cosmetic until they affect access, investment, or execution. In this case, the bigger signal is that Boehringer appears to be deepening its long-term commitment to Georgia as a regional animal health hub. With headquarters functions in Johns Creek and R&D and manufacturing assets already established in Athens and Gainesville, the company is concentrating leadership, science, and production within one state. That can support faster coordination across product development, supply, technical services, and customer-facing teams. It may also strengthen the Southeast’s role in recruiting veterinary, regulatory, and life sciences talent. (gov.georgia.gov)
There’s also a broader competitive context. Large animal health companies have been investing not just in products, but in physical footprints that help them attract talent and integrate commercial and scientific operations. Boehringer’s U.S. animal health business traces its roots in part to the 2017 integration of Merial, and the company now describes a U.S. network of seven sites and more than 3,000 employees. Against that backdrop, the Johns Creek opening looks like less of an isolated real estate story and more like an infrastructure move inside a mature, scale-driven animal health business. (en.wikipedia.org)
What to watch: The next signals will be whether Boehringer updates official location materials, expands hiring around the new headquarters, and uses the Johns Creek base to launch new veterinary, livestock, or innovation initiatives tied to its existing Georgia R&D and manufacturing network. (animalhealth.boehringer-ingelheim.com)